Daily BriefsECM

Daily Brief ECM: ECM Weekly (6th August 2023) – Concord Biotech and more

In today’s briefing:

  • ECM Weekly (6th August 2023) – Concord Biotech, SBFC Fin, Fadu, Mitsui Fudosan, Capitaland Ascott


ECM Weekly (6th August 2023) – Concord Biotech, SBFC Fin, Fadu, Mitsui Fudosan, Capitaland Ascott

By Clarence Chu

  • Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
  • In the IPO space, Concord Biotech Ltd (658823Z IN) and  SBFC Finance Limited (1547353D IN) opened their respective IPO bookbuilds this week.
  • On the Placements front, India began picking up steam post-earnings seasons.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars